US · UTMD
Utah Medical Products, Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Midvale, UT 84047-1048
- Website
- utahmed.com
Price · as of 2025-12-31
$65.77
Market cap 213.4M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $487.29 | +640.9% |
| Intrinsic Value(DCF) | $42.63 | -35.18% |
| Graham-Dodd Method(GD) | $48.58 | -26.13% |
| Graham Formula(GF) | $8.81 | -86.61% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $23.58 | $62.02 | $136.90 | $3.09 | $115.82 |
| 2012 | $37.70 | $40.22 | $169.87 | $8.89 | $47.96 |
| 2013 | $45.51 | $67.04 | $100.01 | $12.41 | $17.05 |
| 2014 | $49.30 | $55.62 | $37.56 | $13.20 | $30.28 |
| 2015 | $52.16 | $87.13 | $22.32 | $14.97 | $17.12 |
| 2016 | $52.76 | $58.87 | $20.86 | $15.37 | $19.48 |
| 2017 | $81.71 | $88.08 | $33.10 | $16.74 | $30.41 |
| 2018 | $77.92 | $75.80 | $34.12 | $28.87 | $47.10 |
| 2019 | $77.32 | $120.58 | $41.03 | $26.63 | $76.09 |
| 2020 | $84.38 | $86.75 | $22.94 | $22.12 | $0.00 |
| 2021 | $81.98 | $70.28 | $41.98 | $0.00 | $96.58 |
| 2022 | $84.92 | $122.58 | $44.68 | $37.34 | $65.42 |
| 2023 | $66.64 | $108.83 | $34.86 | $36.73 | $19.69 |
| 2024 | $57.49 | $218.12 | $25.51 | $31.21 | $0.00 |
| 2025 | $67.09 | $487.29 | $26.45 | $48.58 | $8.81 |
AI valuation
Our deep-learning model estimates Utah Medical Products, Inc.'s (UTMD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $487.29
- Current price
- $65.77
- AI upside
- +640.9%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$42.63
-35.18% upside
Graham-Dodd
$48.58
-26.13% upside
Graham Formula
$8.81
-86.61% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| UTMD | Utah Medical Products, In… | $65.77 | 213.4M | +641% | -35% | -26% | -87% | 19.68 | 1.86 | 5.77 | 7.99 | — | 2.13 | 51.60% | 29.60% | 29.30% | 9.54% | 26.71% | 9.21% | 0.00 | — | 37.62 | 34.36 | -5.03 | -1212.00% | -583.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00% | 1.38% | 11.96 | — | 3.54 | 42.25 |
| CHRS | Coherus Oncology, Inc. | $1.67 | 201.81M | +1,660% | -75% | -94% | +75% | 4.18 | -0.90 | 0.45 | 4.32 | — | -0.64 | 55.97% | -41.83% | 10.68% | -17.52% | -122.98% | 5.29% | -2.04 | -4.11 | 1.21 | 0.88 | 2.36 | -10988.00% | 378.00% | -8833.00% | -17.16% | -0.07 | -22.51% | 0.00% | 0.00% | 196.44% | -2.36 | -12.87 | 0.99 | -4.79 |
| KRMD | KORU Medical Systems, Inc… | $4.77 | 220.96M | +739% | -5% | — | — | -23.86 | 8.61 | 4.30 | -24.53 | — | 9.00 | 63.40% | -19.16% | -18.03% | -32.64% | -52.54% | -21.79% | 0.24 | — | 2.66 | 2.16 | 0.99 | -5667.00% | 1798.00% | -7166.00% | -1.12% | -0.04 | -13.18% | 0.00% | 0.00% | 0.07% | -21.59 | -86.04 | 4.14 | 7.82 |
| NYXH | Nyxoah S.A. | $4.08 | 152.37M | +571% | +9% | — | — | -4.96 | 2.47 | 61.97 | -3.74 | -29.59 | 4.46 | 65.67% | -1300.80% | -1310.24% | -53.42% | -113.83% | -39.94% | 0.20 | -30.90 | 4.56 | 4.13 | 0.20 | 1677.00% | 398.00% | -79.00% | -19.74% | -2.29 | -107.03% | 0.00% | 0.00% | 0.94% | -3.69 | -3.93 | 48.05 | 1.18 |
| OSUR | OraSure Technologies, Inc… | $3.15 | 230.38M | +1,022% | -63% | — | +744% | -3164.74 | 0.64 | 1.89 | -3.83 | -1210.05 | 0.64 | 41.90% | -59.23% | -59.76% | -0.02% | -27.37% | -0.02% | 0.00 | — | 6.58 | 0.01 | 0.00 | 26154.00% | -3810.00% | -10023.00% | -0.02% | 0.00 | -0.02% | 0.00% | 0.00% | 6.91% | -3.19 | -4083.36 | 1.89 | 2.48 |
| PRE | Prenetics Global Limited | $16.91 | 237.65M | +204% | +11,114% | — | — | -4.22 | 1.27 | 2.41 | -4.86 | -30.15 | 1.71 | 52.98% | -40.46% | -63.13% | -30.55% | -32.70% | -25.27% | 0.01 | -155.12 | 3.01 | 2.33 | 0.89 | 1401.00% | 20172.00% | -2645.00% | -9.89% | -0.79 | -19.26% | 0.00% | 0.00% | 0.00% | -4.37 | -7.42 | 1.77 | 4.78 |
| PROF | Profound Medical Corp. | $7.61 | 229.84M | +279% | -61% | — | — | -6.11 | 2.81 | 16.71 | -4.69 | — | 2.82 | 65.89% | -309.57% | -260.45% | -60.70% | -267.75% | -48.72% | 0.08 | — | 10.52 | 9.44 | 1.95 | -2074.00% | 4123.00% | 373.00% | -13.80% | -3.57 | -199.52% | 0.00% | 0.00% | 18.51% | -3.82 | -5.12 | 11.81 | 5.24 |
| STIM | Neuronetics, Inc. | $1.34 | 91.77M | +1,696% | +34,643% | — | — | -3.68 | 5.81 | 2.15 | -6.51 | -11.71 | -15.27 | 72.32% | -46.15% | -58.36% | -141.29% | -54.52% | -34.06% | 2.98 | -4.74 | 1.86 | 1.41 | -1.84 | 3143.00% | 496.00% | -565.00% | -20.18% | -0.99 | -51.22% | 0.00% | 0.00% | 0.00% | -6.48 | -6.90 | 2.99 | -3.34 |
About Utah Medical Products, Inc.
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
- CEO
- Kevin L. Cornwell
- Employees
- 155
- Beta
- 0.35
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($42.63 ÷ $65.77) − 1 = -35.18% (DCF, example).